Is computerised CBT really helpful for adult depression?-A meta-analytic re-evaluation of CCBT for adult depression in terms of clinical implementation and methodological validity by Mirai So et al.
So et al. BMC Psychiatry 2013, 13:113
http://www.biomedcentral.com/1471-244X/13/113RESEARCH ARTICLE Open AccessIs computerised CBT really helpful for adult
depression?-A meta-analytic re-evaluation of
CCBT for adult depression in terms of clinical
implementation and methodological validity
Mirai So1*, Sosei Yamaguchi2, Sora Hashimoto3, Mitsuhiro Sado4, Toshi A Furukawa5 and Paul McCrone6Abstract
Background: Depression is a major cause of disability worldwide, and computerised cognitive behavioural therapy
(CCBT) is expected to be a more augmentative and efficient treatment. According to previous meta-analyses of
CCBT, there is a need for a meta-analytic revaluation of the short-term effectiveness of this therapy and for an
evaluation of its long-term effects, functional improvement and dropout.
Methods: Five databases were used (MEDLINE, PsycINFO, EMBASE, CENTRAL and CiNii). We included all RCTs with
proper concealment and blinding of outcome assessment for the clinical effectiveness of CCBT in adults (aged 18
and over) with depression. Using Cohen’s method, the standard mean difference (SMD) for the overall pooled
effects across the included studies was estimated with a random effect model. The main outcome measure and the
relative risk of dropout were included in the meta-analysis.
Results: Fourteen trials met the inclusion criteria, and sixteen comparisons from these were used for the largest
meta-analysis ever. All research used appropriate random sequence generation and Intention-to-Treat analyses (ITT),
and employed self-reported measures as the primary outcome. For the sixteen comparisons (2807 participants)
comparing CCBT and control conditions, the pooled SMD was −0.48 [95% IC −0.63 to −0.33], suggesting similar
effect to the past reviews. Also, there was no significant clinical effect at long follow-up and no improvement of
function found. Furthermore, a significantly higher drop-out rate was found for CCBT than for controls. When
including studies without BDI as a rating scale and with only modern imputation as sensitivity analysis, the pooled
SMD remained significant despite the reduction from a moderate to a small effect. Significant publication bias was
found in a funnel plot and on two tests (Begg’s p = 0.09; Egger’s p = 0.01). Using a trim and fill analysis, the SMD
was −0.32 [95% CI −0.49 to −0.16].
Conclusion: Despite a short-term reduction in depression at post-treatment, the effect at long follow-up and the
function improvement were not significant, with significantly high drop-out. Considering the risk of bias, our
meta-analysis implied that the clinical usefulness of current CCBT for adult depression may need to be
re-considered downwards in terms of practical implementation and methodological validity.
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Depression is recognised as a major cause of disability all
over the world [1]. It has also been recently emphasised
that it is not a highly recoverable disorder, even when
treated with established pharmacotherapy [2], challenging
previously widely-held ideas on its treatability [3]. There-
fore, there is a great amount of expectation placed on
evidence-based cognitive-behavioural therapy (CBT) [4]
as an alternative or addition to pharmacotherapy [5,6]. It
is hypothesised that reconstructing distorted cognition or
inadaptable behaviour with CBT is likely to lead to the
reduction of symptoms [7]. In fact, there has been increas-
ing attention paid to CBT because of several of its
advantages, including its significant effectiveness against
mild-to-moderate depression [8], the enhancement of
quality of life [9], increase in adherence to pharmacother-
apy [3], comparative advantage for pregnant women [10]
and patients’ preferences [11]. Also, CBT seems to be
beneficial as an early intervention or relapse prevention
measure [12] and CBT is recommended by the National
Institute for Health and Clinical Excellence (NICE) in
preference over routine pharmacotherapy as a treat-
ment for milder depression [13]. Nevertheless, making
CBT widely used requires addressing inevitable resource
allocation problems, including accessibility and cost-
effectiveness [14]. Therefore, the advantages and practical-
ity of self-help treatments including computerised CBT
(CCBT), i.e. self-help CBT using a programme on a web-
site or on a computer without an online network, have
been attractive, and it is believed that self-help CBT will
be an efficacious intervention, especially for mild-to-mod-
erate depression [15]. There are now even greater expecta-
tions of CCBT, owing to its increased potential due to
technological progress in terms of interactivity, multi-
media functions and flexibility [16]. Since the first
randomised controlled trial (RCT) reported by Selmi in
1990 [17], the number of papers published on CCBT has
increased markedly. Also, to date, there have been five
meta-analyses [18-22] which specifically looked at the ef-
fect of CCBT on adult depression, and all of them found
that CCBT was of benefit with moderate effect sizes.
However, these systematic reviews cannot be considered
to provide definitive and compelling support for CCBT
due to both the lack of two significant perspectives from
clinical implementation and the four issues of methodo-
logical validity.
From the perspective of clinical implementation, one
point is that they have never dealt with functionality. In-
deed, all of the three RCTs carried out to date on the
cost-utility of CCBT [23-25] could not find significant
QALY increases due to the lack of functional improve-
ment. In addition to functionality, on the other hand, it
seems to be also insufficient that even long-term effect-
iveness has not been meta-analysed at all.Considering methodological aspects, it seems that past
meta-analyses have crucial limitations in quality. The
first issue is the heterogeneity of both targeted disorders
and intervention. In the former, three meta-analytic
studies [18,19,21] dealt with depression and other disor-
ders (such as anxiety disorders) as common target dis-
orders, implying a critical bias in the results due
to considerable diagnostic heterogeneity, as CBT for
depression and that for other disorders, such as anxiety
disorders, are theoretically different interventions. In-
deed, in these three, the effect sizes of CCBT for anxiety
were generally greater than CCBT for depression.
In contrast, two other meta-analyses [22,20] exclu-
sively dealt with depression. Nevertheless, there still
remain the heterogeneous problems of intervention.
Gellatly et al. included not only ten CCBT research stud-
ies but also twenty nine studies with non-CCBT inter-
ventions, such as bibliotherapy, indicating that the
results of this meta-analysis cannot be accepted as those
of solely CCBT-intervention. Compared to this review,
Andrews et al. used the largest number to date (eleven)
of RCTs on depression-only CCBT. Even so, this meta-
analysis included two inappropriate studies [17,26], as
mentioned below under Results.
Secondly, the published systematic reviews have not
paid due attention to the problem of dropouts. Some
studies suggest that CCBT has higher attrition rates than
other therapies. However, one meta-analysis by Waller
and Gilbody [27] indicated that there was no significant
difference between CCBT users and controls, but this
meta-analysis had substantial diagnostic heterogeneity
(two depression-specific studies and seven studies spe-
cific to other disorders). Since uneven attrition between
or among intervention arms can be a significant cause of
bias [28], more rigorous consideration needs to be given
to this factor.
Thirdly, the published meta-analyses have not exam-
ined publication bias in the available literature on
CCBT.
Lastly, there have been an increasing number of new
studies published since the most recent systematic
review.
Therefore, we conducted a meta-analysis of clinical
effectiveness of single CCBT for adult depression, taking
the above methodological factors into consideration with
an additional evaluation of functional outcomes and
long-term follow-up effects.
Methods
Identification and selection of studies
All RCTs completed and analysed by 11 July, 2011 were eli-
gible for inclusion in this review. Five bibliographic data-
bases were used [MEDLINE (1948 to July 2011), PsycINFO
(1806 to July 2011), EMBASE (1980 to 2011), CENTRAL
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2011)]. We also searched www.controlled-trials.com. Mul-
tiple search terms were used (Appendix) and modified for
each database, as necessary. The search was performed on
11 July, 2011.
We included 1) randomised trials 2) in which the effects
of guided and unguided CCBT specific to depression 3)
were compared with one or more control conditions 4) in
individuals aged 18 years or older 5) with depression, and
in which 6) reliable and standardised rating-scales were
equally used both at baseline and follow-up. Also, we only
included studies 7) with proper allocation, concealment,
and single or greater blinding of outcome assessment; and
8) trials using medications or other psychotherapies were
included. We excluded studies on 1) inpatients, because
we excluded patients with severe symptoms from self-help
intervention, and those with 2) comorbidities such as
psychotic disorders, manic status, dementia and severe
physical conditions. In fact, we had originally intended to
distinguish between patients on waitlists from treatment
as usual (TAU), because we considered there to be restric-
tions on administration of medications to patients on
waitlists. Nevertheless, the proportion of subjects taking
medication at waitlist baseline was very similar to that
with TAU, and medication was mostly not controlled.
Therefore, we decided to group together both of these,
and checked the influence of this factor on outcomes
through a subgroup analysis. This grouping seemed to be
justified because the above past five meta-analyses had
treated data likewise. Studies had to have a primary end-
point including a measure of depression at the outcome
assessment immediately after intervention and at long
follow-up (if applicable). We defined long follow-up as
follow-up where the final assessment was more than six
months after treatment, because this is a recovery period
associated with low future recurrence of depression [29].
Function at post-treatment and the number of total drop-
outs were adopted as secondary endpoints.
Meta-analyses
Intervention effects were expressed using various types
of rating scales for common outcomes, thus the effect
sizes using standardized mean differences (SMDs) with
95% confidence intervals for post-treatment were com-
puted, and then incorporated into the meta-analysis and
presented with 95% confidence intervals. Where trials
used a number of different tools to assess depression, we
included the main outcome measure following our hier-
archy, including the primary endpoint or endpoint first
reported in the results.
Statistical heterogeneity was evaluated through a SMD
forest plot. Cochrane’s Q statistic (chi-squared test) was
performed with a significance level of 0.10. Furthermore,
the I-squared (I [2]) statistic for heterogeneity was alsoused for confirmation of Cochrane’s Q statistic. A
random-effect model was selected due to the large
heterogeneity of each clinical design and participants.
All meta-analyses were performed using Review Man-
ager (RevMan ver. 5.1). Subgroup analyses were per-
formed for the type of control (Waitlist and TAU). Also,
we re-evaluated the clinical effectiveness through a sen-
sitivity analysis by excluding Beck Depression Inventory
I, BDI- I [30], and II [31], or according to the difference
in attrition rates and imputation techniques. The reason
for the former is that, particularly in CCBT studies pri-
marily relying on self-rating scales, measurement bias is
suspected due to differences between the scales
employed, and it is necessary to avoid this giving rise to
underestimation. The reason for the latter is that high
dropout rates were expected [27], thus we also per-
formed an analysis excluding research with attrition
rates higher than 20% (such rates probably had an influ-
ence on the results irrespective of ITT according to
Cochran handbook) [32], significantly higher dropout
RRs or non-modern imputation processing.
A funnel plot was used as a test of the main outcome
to detect publication or reporting bias through visual in-
spection. Begg’s [33] and Egger’s [34] tests were also
conducted for statistical checking. When a significant
small study effect was noted, we assessed its influence
through the trim-and-fill method [35].
It seems that adequate missing value management is
useful in carrying out appropriate CCBT evaluation,
because we expect overall attrition rates to be high.
Although it was physically unfeasible for us to collect all
the original data without imputation, in the present
meta-analysis we considered the potential impact on the
review result through a sensitivity analysis in terms of
the influence of imputation. Also, the modern imput-
ation was defined as an imputation needing more com-
plex processing than classic and comparatively simple
imputations such as last observation carried forward
(LOCF) or mean imputation (MI).
Results
Characteristics of included studies
Out of 4,888 studies initially screened, following the
process shown in Figure 1, fourteen were identified as
relevant to the investigation of the clinical-effectiveness
of CCBT as the sole intervention (Table 1). All continu-
ous mean and SD values of post-treatment primary out-
come data were available, and data from all 14 were
finally used for 16 comparisons in the meta-analysis, as
mentioned below (Table 2). In this inclusion process, we
excluded two significant studies by Selmi et al. [17] and
Wright et al. [26] that were included in all of the five
prior meta-analyses mentioned above, because we ultim-





Figure 1 Process of study selection: PRISMA flow diagram.
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concealment and random sequence generation. The
other, by Wright et al., was not regarded as being a study
on self-help, due to highly intensive assistance of eight
standard CBT sessions.
There were more women than men subjects, and the
mean age ranged from 22.6 years (Clarke 2009) to 55 years[44] (see the Characteristics of included studies table).
The majority of CCBT programmes were based on stand-
ard CBT, while combined CBT with other therapies was
used in two trials. All studies used a self-reported measure
of depression as their primary outcome, and eight trials
mainly used BDI. All studies stated that allocation con-
cealment and ITTs were adequately performed. There
Table 1 Selected characteristics of randomised controlled studies examining the effect s of CCBT for adult depression
First author and year of
publication






Control group F-U Attrition
rate (%)
Imputation Country
Andersson (2005) [36] community guided iCBT, 5 117 BDI, MADRS QOL WL (online
discussion group)
6 months 27% LOCF Sweden
Christensen (2004) [37] community unguided iCBT, 5 525 CES-D na Attention placebo 6 weeks 20% LOCF Australia
Clarke (2002) [38] vio HMO unguided iCBT, 7 299 CES-D na TAU 8 months 41% unclear USA
Clarke (2005)a vio HMO unguided iCBT, 7 +
postcard-reminder
175 CES-D SF-12 TAU 16 weeks 34% REML USA
Clarke (2005)b vio HMO unguided iCBT, 7 +
telepone-reminder
180 CES-D SF-12 TAU 16 weeks 34% REML USA
Clarke (2009) [39] vio HMO unguided iCBT, 4 160 PHQ-8 na TAU 8 months 37% REML USA
de Graaf (2009) [40] community unguided iCBT, 8 or 9 303 BDI-ii SF-36 TAU 6 months 5% MI the Netherlands
Meyer (2009) [41] community guided iCBT, 8 396 BDI WSAS WL 6 months 31% replaced by
pretreatment scores
German
Perini (2009) [42] community guided iCBT, 8 45 PHQ-9, BDI-ii SDS WL 8 weeks 27% replaced by
pretreatment scores
Australia
Ruwaard (2009) [43] community guided iCBT, 11Weeks 54 BDI WBQ WL 18 months 9% WOCF the Netherlands
Spek (2007) [44] community unguide iCBT, 8 301 BDI-ii, EDS na WL 2 weeks 40% MI the Netherlands
Titov (2009)a community technician-guided iCBT, 8 81 PHQ-9, BDI-ii SDS WL 16 weeks 8% LOCF Australia
Titov (2009)b community clinician-guided iCBT, 8 86 PHQ-9, BDI-ii WBQ WL 16 weeks 8% LOCF Australia
van Straten (2008) [45] community guided iCBT, 4 213 CESD, MDI EuroQoL WL 4 weeks 17% MI the Netherlands
Venrnmark (2010) [46] community guided iCBT, 8 88 BDI, MADRS QOL WL 6 months 14% LOCF Sweden
Warmerdam (2008) [47] community guided iCBT, 8 263 CESD EuroQoL WL 12 weeks 40% LMM the Netherlands
iCBT, Internet-based Cognitive Behavioural Therapy; cCBT, Computer-based Cognitive Behavioural Therapy; BDI, Beck Depression Inventory; MADRS, Montgomery Asberg Depression Rating Scale; HADS, Hospital Anxiety
and Depression Scale; CESD, Centre for Epidemiological Studies Depression Scale; PHQ-9, Patient Health Questionnaire 9-item; EDS, Edinburgh Depression Scale; MDI; Major Depression Inventory; QOL, Quality of Life
Inventory; WSAS, Work and Social Adjustment Scale; SF-12(36), Short Form 12(36) Health Survey; WBQ, Well-Being Questionnaire; SDS, Sheehan Disability Schedule; WL, Waitlist; TAU, Treatment as Usual; LOCF, Last

















Table 2 Data and analyses
Comparison 1. CBT versus control




Statistical method Effect estimate
1 Reduction in depression symptoms post
treatment
16 2807 Std. Mean Difference (IV, Random, 95% CI) −0.48 [−0.63. -0.33]
2 Reduction in depression symptoms at long
follow-up
5 976 Std. Mean Difference (IV, Random, 95% CI) −0.05 [−0.19, 0.09]
3 Improvement in function at post-
treatment
13 2008 Std. Mean Difference (IV, Random, 95% CI) −0.05 [−0.31, 0.22]
4 Relative risk of attrition at post-treatment 16 2807 Risk Ratio (M-H, Random, 95% CI) 1.68 [1.31, 2.16]
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tions for 7 trials, one study (Titov 2009) [48] finished the
follow-up of only the intervention group, and thus control
data were not available. Another study [43] presented the
results of the follow-up at 18 months by transforming a
waiting-list group into an intervention group after a first-
phase trial, and therefore could not be included in the
current meta-analysis. Ten clinical-effectiveness studies
recorded functional change as well as mood. Also, all 14
studies showed the post-intervention attrition rate. Two
studies (Clarke 2005 [49] and Titov 2009 [48]) that each
had three branches in the original research were respect-
ively divided into two comparisons, and they were identi-
fied as Clarke 2005a and Clarke 2005b (post-card
reminder or telephone reminder with CCBT) in the
former, and as Titov 2009a and Titov 2009b (either
technician-assisted or clinician-assisted CCBT) in the
later, thereby giving a total of 16 comparisons from 14 ori-
ginal studies for the meta-analysis.Figure 2 Comparison: CCBT versus control, Outcome: Reduction in dePrimary and secondary outcomes
We included 16 comparisons (2807 participants) in
terms of the reduction in depression symptoms between
CCBT and controls following treatment (Figure 2). The
pooled SMD was −0.48 [95% CI −0.63 to −0.33], indicat-
ing a significant moderate effect. Reduction in depres-
sion symptoms at long follow-up (Figure 3): The pooled
SMD from the five studies (976 participants) that pro-
vided long-term follow-up data was −0.05 [95% CI −0.19
to 0.09], indicating no significant difference between the
groups. Improvement in function at post-treatment
(Figure 4): The pooled SMD from the twelve compari-
sons that provided data on function at post-treatment
was −0.05 [95% CI −0.31 to 0.22], indicating no signifi-
cant difference between two groups. In addition, the
pooled relative risk from all trials providing data on
attrition at post-treatment (Figure 5) was 1.68 [95% CI
1.31 to 2.16], indicating a significant difference between
the two groups.pression symptoms at post-treatment.
Figure 3 Comparison: CCBT versus control, Outcome: Reduction in depression symptoms at long follow-up.
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We attempted to analyse the differences in effects between
studies where the control was a waiting list and those
where it was TAU (Figure 6). The control was a waitlist in
nine comparisons [36,37,41,44,45-47,48], while it was TAU
in seven comparisons [38-40,42,43,49]. The pooled SMD
for waitlist-controlled trials was −0.63 [95% CI −0.83 to
−0.45], indicating a moderate effect. By contrast, the
pooled SMD for TAU-controlled trials was −0.23 [95% CI
−0.37 to −0.09], indicating a small effect. There was a sig-
nificant difference between two groups.Sensitivity analyses
Sensitivity analyses were conducted as show below.Rating scales except BDI
For the seven comparisons that employed neither BDI -I
nor -II as the primary outcome measure [37-39,45,47,49],Figure 4 Comparison: CCBT versus control, Outcome: Improvement inthe SMD was −0.32 [95% CI −0.48 to −0.17], indicating a
small clinical effect in favour of CCBT.
Acceptable attrition rate (<20%)
For the seven comparisons that were reported to have
an acceptable dropout rate (<20%) [37,40,43,45,46,48],
the SMD was −0.59 [−0.85, -0.34], showing a moderate
clinical effect in favour of CCBT.
Imputation techniques
For the nine comparisons without a significant differ-
ence in attrition rate between intervention and control
at post-treatment [37,39,40,42-44,46,48], the SMD was
−0.50 [95% CI −0.73 to −0.27], showing a moderate clin-
ical effect in favour of CCBT. On the other hand, for the
eight comparisons from seven trials with modern imput-
ation techniques [38,39, 43-45,47,49], the SMD was −0.34
[95% CI −0.51 to −0.18], indicating a small clinical effect
(of borderline significance) in favour of CCBT.function at post-treatment.
Figure 5 Comparison: CCBT versus control, Outcome: Relative risk of attrition at post-treatment.
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We explored publication bias, using a Funnel plot (Figure 7).
The plot can be seen to be asymmetric, indicating a rela-
tionship between intervention effect and study design. In
particular, this asymmetry suggests a publication bias to-
ward larger effect size in smaller studies, since there was a
marked concentration of studies shown on the left side in
the lower part of the plot. It was inferred that smaller stud-
ies with larger effect sizes were more likely to be published,
and thus they had a higher probability of demonstrating
statistical significance. Also, there was significant statisticalFigure 6 CCBT versus control: subgroup analyses – type of control (W
at post-treatment.evidence for study bias using both Begg’s test (p = 0.009)
and Egger’s test (p = 0.01). Using the trim and fill analysis,
the SMD was −0.32 [95% CI −0.49 to −0.16].
Discussion
We analysed 16 comparisons from 14 publications,
targeting the largest size and highest quality meta-analysis.
Consequently, this review found that CCBT has appar-
ently a moderate post-treatment effect size (SMD −0.48,
95% CI −0.63 to −0.33) for adult depressive symptoms
compared with control conditions, indicating almost theaitlist and TAU), Outcome: Reduction in depression symptoms
Figure 7 Funnel plot of comparison: CCBT versus control, outcome: reduction in depression symptoms at post-treatment. White circles:
included comparisons. Black circles: imputed comparisons using the trim-and-fill methods. White diamond: pooled observed standard mean
difference. Black diamond: pooled imputed standard mean difference.
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we further found a possibility that this result may have
to be re-considered downward in terms of practical im-
plementation and research methodology. Thus, we
would like to examine these two aspects.
Considering the lack of the endurance of effectiveness,
functional improvement and the high dropout rate, our
result inevitably casts doubt on the actual practicability
of the current CCBT for depression.
To begin with, the attenuation of long-term effective-
ness with CCBT seems to be a serious issue from a clin-
ical point of view. In fact, although one of the past
reviewers [20] implied this tendency, long follow-up has
not been clearly reviewed in meta-analyses until today.
In this context, ours is the first review to meta-analyse
long follow-up outcomes. This was paradoxical from the
perspective that it has been reported that the effect of
standard face-to-face CBT on depression does not usu-
ally attenuate sharply after intervention even without
maintenance sessions. For example, the latter view has
been advocated by the Annual Review of Psychology
[50], which mentions that the effectiveness of CBT appears
to be at least more enduring than that of antidepressants
for depressive patients. However, it is still unclear why such
variance could arise according to differences in modality,
while van Londen et al. raised this question in the context
of bibliotherapy [51].In addition to long follow-up outcomes, it also has not
been meta-analysed until our study about whether
CCBT can contribute to functional improvement, even
though this outcome is critically important in view of
evaluating cost-utility, which is referred to as a distinct-
ive advantage of CCBT [15]. In our analysis, CCBT
intervention did not provide a significant effect in terms
of function. There are a few possible reasons for this.
Firstly, current CCBT may not be fundamentally good
enough to improve function. The attainment of social
functions such as returning to work has been commonly
recognised as being more difficult than simply reducing
depressive symptoms [52]. Secondly, we may have to
consider the scale-sensitivity of function. Revicki et al.
also referred to the property of generic measures that
improvements in those scores are less sensitive in less
depressive patients [53]. They suggested that such
generic scales were even more unlikely to change
amongst mild-to-moderate depressive patients than in
severe depressive patients, often resulting in little change
in utility and problematic utility assessment.
The third issue with practical implementation is that
more than half of included studies had high overall drop-
out rates. It is clear that the higher dropout is unavoidable,
especially for depression remediation, in that poor motiv-
ation is one of the fundamental symptoms. Indeed, even
in the NHS, the dropout rate from CCBT is also high,
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pression not completing it, and it seems that this needs to
be addressed as a serious issue [54].
Despite the above substantial limitations of CCBT, it is
still used on the premise that it is significantly effective,
at least as measured immediately following treatment
with it. However, by addressing methodological issues,
our analysis further revealed some findings that may
raise a more fundamental question of whether CCBT is
really effective for adult depression even following
treatment.
The first finding is the ambiguous definition of control
conditions. In all previous systemic reviews of CCBT,
there was little clarification of the influence of grouping
results from studies with TAU and the waitlist as con-
trols. Unlike research on medications or psychotherapy,
all RCTs on CCBT effectively did not restrict the usage
of medications for waitlist groups. Therefore, we had
held that this confusion between groups without suffi-
cient presentation is a considerable problem, and set up
a protocol to separate subjects on waitlists from those
undergoing TAU. However, we found that the propor-
tion of patients taking medication at baseline for TAU
groups was in the range from 0% to 76%, and the range
for control groups was from 37% to 74%. When consid-
ering the virtually undistinguishable rates of medication
intake, we concluded that it was difficult to clearly sep-
arate TAU from waitlist data, and that is why we classi-
fied TAU and waitlist subjects into the same control
group in a post-hoc decision, adding a subgroup analysis
on the influence of doing this.
In the subgroup analysis, our results showed that the
effects were significantly greater when the control group
was a waitlist as opposed to TAU. Only a meta-
regression [20] had an identical finding to ours, although
the analysis was conducted by using only four (10.2%)
reliable studies with depression-specific CCBT interven-
tion. In general, this type of difference seems rational be-
cause TAU is more therapeutically intensive than a
waitlist. However, another likely cause is that the reason
for this is due to the tendency for it to be fundamentally
easier for an intervention group to indicate a greater ef-
fect size relative to a waitlist than active placebo in psy-
chotherapy research [55]. Therefore, it has been recently
recommended to not use waitlists in research designs be-
cause of overestimation of intervention. Either way, this
issue should be treated more carefully in general RCT set-
tings as well as in RCTs of CCBT.
The second issue was that a high attrition rate was
also considered to lead to a significant bias despite the
conduct of ITT throughout all included studies. In prac-
tice, Cochran states that attrition rates higher than 20%
may even affect outcomes analysed using ITT [32]. Also,
extremely uneven attrition between or among branchesof intervention can be an impermissible cause of bias
[28]. Only one meta-analysis by Waller and Gilbody has
dealt with this attrition issue, finding that subjects
treated with CCBT dropped out approximately twice as
frequently as control subjects, but this finding was not
statistically significant [27].
In relation to the high dropout rate, we focused on the
fact that a variety of imputation techniques were
implemented for ITT in order to cover attrition in each
study, but there was no research on CCBT which exam-
ined this risk by this kind of imputation. Rickels and
Schweizer mentioned that ITT takes account of drop-
outs, usually by LOCF [56]. However, Shao et al. [57]
and Unnebrink et al. [58] claim that old-type imputations,
such as LOCF, mean imputation and worst observation
carry-forward (WOCF), can cause significant differences
in results when the attrition rate is higher than 20%. By
contrast, modern imputation can be thought as being
more appropriate. Moreover, there can be significant dif-
ferences even among imputations, and if so, this issue is
serious for research especially where there is a high level
of attrition. For example, Warmerdam demonstrated that
newer imputation led to significantly different results [25].
Therefore, we investigated the probability of bias due to
the method of imputation. In fact, when only trials with
modern imputation techniques were included, the effect
size decreased from moderate to mild. The influence of
imputation has not been seriously discussed in psycho-
therapy, including self-help. In particular, research on
CCBT should give more consideration to this because of
its high attrition rate relative to other psychotherapies.
Thirdly, our study was the first to detect significant
publication bias specific to CCBT, and this suggested
the necessity of careful re-consideration in evaluating
the usefulness of CCBT. Indeed, the trim-and-fill
method suggested that the SMD reduced from −0.48
[95% CI −0.63 to −0.33] to −0.32 [95% CI −0.49 to −0.16],
but still indicating significant effectiveness at least at post-
treatment.
Finally, we cannot overlook the fact that there has
been a remarkable dominance of self-rating scales used
as the primary endpoints of past CCBT research. In our
analysis, self-rating scales were used as the primary out-
come in all studies. Although all the adopted scales were
academically reliable as screening tools, excessive expec-
tations as to self-rating measures could lead to signifi-
cant bias in the results because self-report ratings from
depressed patients are not necessarily a reliable or
definitive estimate of the severity especially during the
acute phase including before symptomatological im-
provement [59].
Our sensitivity analysis also demonstrated that the
effect size at post-treatment reduced from moderate to
small without BDI. This can be explained by the
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cantly influenced by cognitive factors rather than other
instrumentals due to the different conceptualisation of
depression among scales [60,61]. Indeed, CCBT is more
likely to improve BDI scores than other measures prob-
ably because CCBT programmes strategically target cog-
nitive change. Further, it has been also discussed that
BDI is inaccurate as a way of appraising treatment out-
comes due to overreactivity [62,63]. The frequent use of
BDI can be theoretically justified as an efficacy study
aiming at the efficacious maximisation of intervention.
Even so, in terms of generalisablity, we may need to
keep in mind the risk of overestimation when using
self-rating scales, including BDI, when actually
adopting CCBT for clinical use.
It is seemingly reasonable to expect that self-help
CCBT can be a clinically- and cost-effective intervention,
considering prior wholly-supportive reviews; however,
the use of CCBT, even for mild to moderate depres-
sion, may be less practical and efficacious than believed
at present. This can be supported by the poor results of
three available cost-utility analyses of depression CCBT
[23-25]. Nevertheless, it would be too extreme to con-
clude that CCBT is an inefficacious intervention for
adult depression for a few reasons. Firstly, we could dis-
tinguish indications for which CCBT is appropriate. In
fact, it has been reported that applying CCBT to patients
with a personality suitable for it [64] or to those from a
technologically-literate generation [19] may contribute
to better outcomes. Also, further development of CCBT
in terms of sophistication and attractiveness accompany-
ing the rapid progress of information technology [65]
might enhance the effectiveness of and adherence to
CCBT, such as in the format of a therapeutic computer
game [66].
Our review has a few limitations. Firstly, we should
have ideally recalculated the effect size (SMD) of each
outcome from the original research data in order to en-
hance the review quality [32]. However, we could not do
this due to physical and time restrictions. Secondly, we
could not include unpublished data or data from on-
going trials even though we attempted to collect them
using several ways.
Conclusion
This review found that CCBT seems to improve depres-
sive symptoms at post-intervention among adults follow-
ing treatment. However, the effect at long follow-up and
the improvement of function were not significant, and a
considerable dropout rate was also found. Also, there
was significant publication bias and other influential
methodological problems including with self-rating, con-
trol condition and imputation. This may imply a prob-
ability of overestimation of the effect of CCBT and theneed to further improve it. Nevertheless, it is possible
that we do not need to be too pessimistic about CCBT,
since we might be just midway on a long journey of low
intensity intervention, of which CCBT is one part [67].
More careful research is required for CCBT to develop
more substantially.




2. exp Depressive Disorder/
3. (Depression or depressive or depressed).tw.
4. exp Dysthymic Disorder/
5. Dysthymia.mp.
6. exp Depressive Disorder, Major/
7. exp Affect/
8. exp Mental Disorders/
9. or/1-9
10. exp Internet/
11. exp Therapy, Computer-Assisted/
12. exp Cognitive Therapy/
13. exp Primary Health Care/
14. CCBT.mp.






21. exp Cognitive Therapy/
22. Self-help.tw.
23. Medical informatics computing.mp.
24. exp Medical Informatics Computing/
25. exp Multimedia/
26. exp Computer-Assisted Instruction/
27. Computer assisted instruction.mp.




32. Therapy, computer assisted.tw.
33. Web-based.mp.
34. Web-based.tw.
35. Beating the blues.mp.





41. exp Psychotherapy, Multiple/
42. exp Psychotherapy, Group/
43. exp Psychotherapy, Brief/
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64. exp Randomized Controlled Trial/
65. Randomized controlled trial.mp.
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PsychINFO
1. exp "Depression (Emotion)"/
2. exp Major Depression/
3. Depression.mp.
4. (Depression or depressive or depressed).af.
5. dysthymia.mp. or exp Dysthymic Disorder/
6. or/1-5
7. Internet.mp. or exp Internet/or exp Internet Usage/
8. exp Cognitive Therapy/
9. exp Computer Applications/
10. exp Computers/
11. exp Computer Assisted Therapy/
12. exp Computer Assisted Instruction/
13. Therapy, Computer-Assisted.mp.
14. exp Computer Software
15. Computer assisted.af.
16. exp Computer Assisted Therapy/
17. Ccbt.mp.
18. exp Self Help Techniques/
19. ccbt.af.
20. Bibliotherapy.mp. or exp Bibliotherapy/
21. exp Online Therapy/or self-help.mp.
22. Self-help.af.23. Web-based.mp.
24. Beating the blues.af.
25. or/7-24
26. exp Brief Psychotherapy/
27. exp Group Psychotherapy/
28. exp Psychotherapy/
29. exp Analytical Psychotherapy/
30. exp Individual Psychotherapy/
31. exp Interpersonal Psychotherapy/
32. exp Psychodynamic Psychotherapy/
33. tau.af.











45. exp Clinical Trials/or exp Intervention/or
randomized controlled trial.mp.




50. (Cognitive adj2 therap$).af.
51. ((Behaviour& or behavior&) adj2 therap&).af.
52. Cognitive Therapy.mp.
53. exp Cognitive Therapy/
54. exp Cognitive Therapy/
55. exp Cognitive Behavior Therapy/
56. cbt.mp.
57. or/50-56
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